Morreau Jane Cecil 4
4 · Vita Coco Company, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Morreau Jane Cecil
Director
Transactions
- Exercise/Conversion
Common Stock
2026-02-23$10.18/sh+5,000$50,890→ 22,179 total - Exercise/Conversion
Common Stock
2026-02-23$10.18/sh+5,000$50,890→ 27,179 total - Exercise/Conversion
Common Stock
2026-02-23$10.18/sh+5,000$50,890→ 32,179 total - Sale
Common Stock
[F1]2026-02-23$53.91/sh−15,000$808,650→ 17,179 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-02-23−5,000→ 40,500 totalExercise: $10.18Exp: 2031-07-12→ Common Stock (5,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-02-23−5,000→ 35,500 totalExercise: $10.18Exp: 2031-07-12→ Common Stock (5,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F2]2026-02-23−5,000→ 30,500 totalExercise: $10.18Exp: 2031-07-12→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option is fully vested and currently exercisable.
Signature
Alison Klein, Attorney-in-Fact For: Jane Morreau|2026-02-24